LivaNova PLC
General ticker "LIVN" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.6B (TTM average)
LivaNova PLC follows the US Stock Market performance with the rate: 62.7%.
Estimated limits based on current volatility of 1.4%: low 62.90$, high 64.52$
Factors to consider:
- Total employees count: 2900 (0.0%) as of 2024
- US accounted for 57.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Cybersecurity threats, Public health crises, Supply chain disruptions, Liquidity and credit risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [37.36$, 61.26$]
- 2025-12-31 to 2026-12-31 estimated range: [35.60$, 58.82$]
Financial Metrics affecting the LIVN estimates:
- Negative: with PPE of 13.9 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 10.57
- Positive: 6.82 < Operating cash flow per share per price, % of 7.20
- Positive: 41.86 < Shareholder equity ratio, % of 52.68 <= 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -0.87 <= -0.75
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: Industry earnings per price (median), % of -3.67 <= 0
Short-term LIVN quotes
Long-term LIVN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $992.27MM | $1,115.72MM | $1,220.39MM |
| Operating Expenses | $1,069.02MM | $1,184.21MM | $1,091.34MM |
| Operating Income | $-76.75MM | $-68.50MM | $129.05MM |
| Non-Operating Income | $1.61MM | $-12.73MM | $-40.74MM |
| Interest Expense | $48.25MM | $58.85MM | $63.07MM |
| R&D Expense | $155.81MM | $193.82MM | $182.51MM |
| Income(Loss) | $-75.14MM | $-81.23MM | $88.31MM |
| Taxes | $11.05MM | $-98.88MM | $25.06MM |
| Other Income(Loss) | $-0.05MM | $-0.10MM | $-0.02MM |
| Profit(Loss)* | $-86.29MM | $17.55MM | $63.22MM |
| Stockholders Equity | $1,207.62MM | $1,277.63MM | $1,320.26MM |
| Inventory | $129.38MM | $147.89MM | $147.57MM |
| Assets | $2,294.77MM | $2,429.56MM | $2,506.39MM |
| Operating Cash Flow | $69.92MM | $74.91MM | $183.04MM |
| Capital expenditure | $26.50MM | $34.98MM | $47.11MM |
| Investing Cash Flow | $-38.41MM | $-40.33MM | $-48.16MM |
| Financing Cash Flow | $280.13MM | $21.48MM | $18.55MM |
| Earnings Per Share** | $-1.61 | $0.33 | $1.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.